PDGFRA and Increased total eosinophil count: In the 2016 and 2022‐updated WHO classifications, stem cell and myeloid neoplasms accompanied by eosinophilia are initially classified based on the presence of certain molecular markers, such as rearranged PDGFRA or PDGFRB (Table S5).8, 9, 10, 11